Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1996;27:811-815

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Doi, K.
Right arrow Articles by Nakao, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Doi, K.
Right arrow Articles by Nakao, K.

(Hypertension. 1996;27:811-815.)
© 1996 American Heart Association, Inc.


Articles

Vascular Endothelial Growth Factor Suppresses C-Type Natriuretic Peptide Secretion

Kentaro Doi; Hiroshi Itoh; Yasato Komatsu; Toshio Igaki; Tae-Hwa Chun; Kazuhiko Takaya; Jun Yamashita; Mayumi Inoue; Takaaki Yoshimasa; Kazuwa Nakao

From the Department of Medicine and Clinical Science, Kyoto (Japan) University Graduate School of Medicine.

Correspondence to Hiroshi Itoh, MD, PhD, Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606, Japan. E-mail hiito@kuhp.kyoto-u.ac.jp.

Abstract Angiogenesis plays a pivotal role not only in wound healing and tumor progression but also in diabetic angiopathy, arteriosclerosis, and collateral formation of obstructive vascular diseases. Vascular endothelial growth factor (VEGF) is now thought to be an endothelium-specific and potent angiogenic factor. We previously demonstrated that C-type natriuretic peptide (CNP), originally isolated from porcine brain, is produced by endothelial cells and proposed that CNP can exert control over vascular tone and growth as a local vascular regulator. In the present study, we examined the effect of VEGF on CNP secretion from endothelial cells using the specific radioimmunoassay for CNP we developed. VEGF (1 to 100 ng/mL) dose-dependently suppressed CNP secretion from cultured bovine endothelial cells, and 100 ng/mL VEGF suppressed endothelial CNP secretion to 28% of control levels (31.7±5.5 versus 8.9±0.8 fmol/mL, vehicle versus VEGF). VEGF also suppressed CNP mRNA expression in endothelial cells 9 hours after administration. In contrast, basic fibroblast growth factor (20 ng/mL), an endothelium-nonspecific angiogenic factor, significantly stimulated CNP secretion by 290%. These results indicate that VEGF can regulate vascular tone and growth in the process of angiogenesis through suppression of endothelial secretion of CNP, which is an endothelium-derived vasorelaxing and growth-inhibitory peptide.


Key Words: natriuretic peptides • endothelial growth factors • endothelial cell • cell division




This article has been cited by other articles:


Home page
EndocrinologyHome page
T. C. R. Prickett, C. W. H. Rumball, A. J. Buckley, F. H. Bloomfield, T. G. Yandle, J. E. Harding, and E. A. Espiner
C-Type Natriuretic Peptide Forms in the Ovine Fetal and Maternal Circulations: Evidence for Independent Regulation and Reciprocal Response to Undernutrition
Endocrinology, August 1, 2007; 148(8): 4015 - 4022.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
D. Rahmutula, J. Cui, S. Chen, and D. G. Gardner
Transcriptional Regulation of Type B Human Natriuretic Peptide Receptor Gene Promoter: Dependence on Sp1
Hypertension, September 1, 2004; 44(3): 283 - 288.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
L. Lavie, H. Kraiczi, A. Hefetz, H. Ghandour, A. Perelman, J. Hedner, and P. Lavie
Plasma Vascular Endothelial Growth Factor in Sleep Apnea Syndrome: Effects of Nasal Continuous Positive Air Pressure Treatment
Am. J. Respir. Crit. Care Med., June 15, 2002; 165(12): 1624 - 1628.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
B. C Kone
Molecular biology of natriuretic peptides and nitric oxide synthases
Cardiovasc Res, August 15, 2001; 51(3): 429 - 441.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Inoue, H. Itoh, M. Ueda, T. Naruko, A. Kojima, R. Komatsu, K. Doi, Y. Ogawa, N. Tamura, K. Takaya, et al.
Vascular Endothelial Growth Factor (VEGF) Expression in Human Coronary Atherosclerotic Lesions : Possible Pathophysiological Significance of VEGF in Progression of Atherosclerosis
Circulation, November 17, 1998; 98(20): 2108 - 2116.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. G. Acuff, H. Huang, and M. E. Steinhelper
Estradiol induces C-type natriuretic peptide gene expression in mouse uterus
Am J Physiol Heart Circ Physiol, December 1, 1997; 273(6): H2672 - H2677.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Pedram, M. Razandi, R.-M. Hu, and E. R. Levin
Vasoactive Peptides Modulate Vascular Endothelial Cell Growth Factor Production and Endothelial Cell Proliferation and Invasion
J. Biol. Chem., July 4, 1997; 272(27): 17097 - 17103.
[Abstract] [Full Text] [PDF]